Know which studies, sites, vendors, and programs need attention.

Clinical development leaders need an operating picture across studies, not a set of disconnected updates. Vivo gives leaders a shared view of trial progress, risk, and performance before issues escalate.

The Challenge

Where teams get stuck today.

  • Portfolio reviews depend on manually assembled updates from each study team
  • Risk escalation arrives after issues have already matured into timeline or quality problems
  • No consistent view of cross-study patterns in sites, vendors, data quality, or enrollment
  • Milestone risk and resource allocation decisions are made from stale, fragmented information
  • Preparing executive reporting requires hours of reconciliation across sources
How Vivo Helps

What Vivo makes possible.

  • Portfolio-level visibility into trial status, risk, performance, enrollment, and milestone pressure
  • Cross-study risk patterns: sites, vendors, data quality trends recurring across programs
  • Portfolio Ask Vivo — ask questions across studies and receive source-backed answers
  • Executive reporting: what-changed summaries, risk snapshots, and milestone views
  • Resource prioritization: surface where leadership attention will have the most impact
  • Drill from portfolio view → study → site → subject → evidence in one platform
Ask Vivo — Example Questions

The questions Portfolio Leadership teams ask Vivo every day.

Ask Vivo

Which studies have the highest execution risk this month?
Which sites or vendors are creating risk across multiple trials?
What changed across the portfolio since the last review?
Which studies are at risk of milestone slippage?
Where should leadership focus attention this week?

"We reached database lock early, even against our stretch goal. That's never happened in my career."

VP, Clinical Operations

See risk, performance, and priorities across studies.

See how Vivo helps clinical development leaders with live trial data, source-backed AI, and governed action workflows.